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DERMATOLOGY

Pemphigoid Gestationis: A Rare Dermatosis of
Pregnancy
Victoria Tran, MS3 and Meghan Belamorich, MD

Figure 1. Bullae at various stages of healing on the abdomen, and medial and
anterior thighs.

Figure 2. Right thigh. Various stages of healing

INTRODUCTION
Pemphigoid gestationis is a rare dermatosis of pregnancy
that often goes unrecognized or misdiagnosed. It can
lead to adverse fetal outcomes including preterm delivery,
low fetal birth weight, and even neonatal pemphigoid
gestationis1. As such, proper diagnosis and management
is critical in reducing fetal risk.

CASE PRESENTATION
A 23 year-old Hispanic G4P2103 woman at 36 weeks and
5 days of gestation presented to the emergency
department with a bullous rash associated with pruritus
and erythema of 1 month duration. The rash started with
a few small pruritic and painful vesicles around her
umbilicus that spread to the rest of her abdomen, legs,
and arms and coalesced to become bullae (Figures 1,2).
Her chest and back had a pruritic, erythematous rash
without bullae (Figure 3), but her fatce, hands, feet, and
oral mucosa were spared.
The patient was initially diagnosed with herpes by her
outpatient provider and was prescribed valacyclovir, but
noted no improvement in her symptoms. Subsequently,
she was thought to have a bullous disease and given a
methylprednisolone dose pack. While the patient
subjectively claimed to feel better, her lesions continued
to progress. She was then referred to an allergist who told
her to go to the emergency department.
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Figure 3. Back rash without bullae

The patient was otherwise healthy and denied a personal
and family history of autoimmune or dermatologic
conditions, a history of drug allergies, recent environmental
exposures, new medications, insect bites, sick contacts,
and travel. No rash was noted with any of her previous
three pregnancies.
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OUTCOME AND FOLLOW-UP
After consultation with internal medicine and dermatology,
the patient was diagnosed with pemphigoid gestationis
based on history and clinical presentation and started on
topical clobetasol to intact lesions and oral prednisone
40mg daily to be tapered once lesions crust over.
During the remainder of her pregnancy, the patient
developed edema and hypertension and labor was
induced. Fortunately, there were no further complications
with her delivery and the infant was born healthy without
any detectable lesions. Figures 1-3 show the patient’s
lesions in various stages of healing, one day after delivery.

DISCUSSION
Pemphigoid gestationis is a rare autoimmune dermatosis
of pregnancy that affects approximately 1 in 50,000
pregnant women in the United States2. While its exact
pathogenesis is not known, it has been postulated to
result from maternal IgG autoantibodies induced by the
paternal major histocompatibility complex class II
antigens in the placenta, the most common being DR-3
and DR-4. The pathologic antibodies cross the placenta
and cross-react with proteins in the maternal skin, leading
to an inflammatory response that ultimately results in the
formation of bullae3,4. Some studies suggest that estrogen
and progesterone may also play a role in disease
pathogenesis, as flare-ups have been demonstrated
immediately post-partum, during menstruation, and with
oral contraceptive use3.
Pemphigoid gestationis typically occurs in the second or
third trimester and initially presents with intensely pruritic,
erythematous papules or plaques around the umbilicus
that spreads to the abdomen, back, chest, and extremities
and eventually form bullae5. Occasionally, as demonstrated
in this case, vesicles are present initially. In many cases,
lesions can extend to the soles and palms, but involvement
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of the face and mucosal surfaces is rare. A detailed history
along with laboratory evaluation which include immunoflourescence and histopathology of skin lesions would
help in coming to a precise diagnosis.
Treatment of this condition is largely symptomatic. The
current standard of care is topical corticosteroids for
localized lesions and systemic corticosteroids if the
topical formulations do not control symptoms. Few case
reports have suggested intravenous immunoglobulin
may be an acceptable treatment option if corticosteroids
cannot be tolerated6 . Because this condition is associated
with an increased incidence in preterm delivery and low
birth-weight neonates, it is important that these patients
deliver in facilities that have a neonatal intensive care unit
and that are prepared to deal with these complications6.
Because pemphigoid gestationis is uncommon in the
United States, it can often be missed or misdiagnosed and
patients may be sent from specialist to specialist, like the
patient in this case. It is important to be able to recognize
this dermatosis to reduce the risk of neonatal complications
and for appropriate management of the neonate.
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